Taxes and the laws governing them are constantly changing, as made evident in the recent changes to how companies have to handle their R&D costs.

Previously, businesses could write off those costs immediately; however, they now must capitalize their R&D costs and view them as assets instead of expenses.

Due to these changes, it’s more important than ever for businesses of all sizes to understand the tax laws and implications surrounding the new R&D laws.

Table of Contents

What Is R&D Capitalization?

Capitalizing R&D costs means treating research and development activities as investments instead of expenses on your financial records.

This financial strategy offers several advantages for business owners, like enhancing your company’s profitability. When you capitalize development costs, you highlight these activities’ long-term value to your organization.

This method becomes especially valuable when presenting your company’s financial health to investors and creditors, as it accurately reflects your true profitability.

This method becomes especially valuable when presenting your company’s financial health to investors and creditors, as it provides a more accurate reflection of your true profitability.

In addition, capitalizing R&D transfers these costs from your profit and loss statement to the balance sheet. By representing R&D expenses as assets, your balance sheet reflects the investments made in innovation and development, which can positively impact how your company’s financial stability and potential for growth are perceived.

This strategic approach not only aligns with accounting standards but also strengthens your financial standing in the eyes of stakeholders, making it a prudent choice for forward-thinking business owners.

Proper filing is more crucial than ever with the new changes made by the IRS. Don’t miss a beat — File your claim with TaxRobot.

R&D Expenses, Capitalization, and Amortization

From an economic standpoint, it makes sense to treat research and development costs as assets on financial records, even though it’s uncertain how much future benefit they will yield. To do this, you estimate the product or technology’s lifespan and use it to determine the amortization period.

This amortization period varies based on the specific asset and mirrors the economic life of different products. For example, R&D products developed by pharmaceutical companies typically last many years due to the lengthy patent approval process, allowing for monopolistic sales over several years.

In contrast, R&D expenses for a tech company should be amortized much faster because new products enter the market rapidly, resulting in shorter lifespans.

This process is often done using the straight-line method, where the expenses are divided equally over the asset’s life. It ensures a fair representation of the costs associated with R&D activities, allowing businesses to accurately reflect their investments in innovation over time.

How Capitalizing R&D Affects Your Business

Research and development spending fluctuates from year to year; this variability can strongly influence a company’s profitability.

When a company doesn’t treat R&D spending as an asset, its reported net income can vary greatly due to the timing of these expenditures. Net income does not account for the substantial investments made in R&D, which are typically categorized separately in the cash flow statement under investing activities.

Interestingly, this situation contradicts a fundamental accounting principle: expenses should align with the period when the corresponding revenue is generated.

Why R&D Regulations Are Changing

For most companies, research and development represents a substantial long-term investment. It leads to years of revenue, cash flow, and profit, making it logical to consider R&D as an asset rather than an immediate expense.

Without capitalizing R&D spending, comparing companies within the same industry becomes challenging — the timing of their research expenditure can significantly impact their financial outcomes in a given year, making it harder to accurately assess their financial performance and investment in innovation.

By capitalizing R&D expenses, businesses can provide a more accurate representation of their financial health and long-term investments. This not only ensures fair comparisons within the industry but also aligns with the economic reality of R&D as a driver of future revenue and profitability.

The Impact of R&D Capitalization

Since January 1, 2022, a new tax regulation mandated businesses to spread their R&D expenses over a period of either five or fifteen years rather than deducting them in the year they were incurred. This change affects businesses significantly, especially those with substantial R&D costs.

There are two key points to consider in this regulation:

Under Section 174, R&D expenses must be capitalized. These expenses might increase a company’s taxable income, potentially affecting the use of their available net operating loss carryforwards.

Depending on how a company is financed, those net operating losses might be restricted by Section 382. Companies dealing with these conditions might find themselves paying cash taxes earlier than they expected and should plan their budgets accordingly.

It’s crucial for businesses, especially those heavily invested in R&D, to be aware of these changes and adapt their financial strategies to accommodate these new regulations. Proper budgeting and understanding of these tax implications are essential to managing cash flow effectively and ensuring financial stability.

Companies Can Still Take Advantage of the R&D Tax Credit

Luckily, it’s not all bad news for businesses with significant R&D expenditures. They can still claim the R&D credit based on expenses incurred during the taxable period. This credit is available at the federal level, and many states offer their own R&D credit.

To claim this credit, companies must have specific, detailed information about their eligible expenses — at a minimum, this means identifying business components used to conduct R&D activities, called qualified research expenditures.

The R&D credit offsets a company’s income tax dollar for dollar; however, qualified small businesses can use it to offset payroll taxes.

Even with the new R&D tax credit rules, many businesses can benefit from their research and development costs. Claim your maximum refund with TaxRobot.